Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

[1]  Anand I. Rughani,et al.  Congress of Neurological Surgeons Systematic Review and Evidence‐Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary , 2018, Neurosurgery.

[2]  J. Ostrem,et al.  Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: A Review , 2018, JAMA neurology.

[3]  G. Deuschl,et al.  Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial , 2018, The Lancet Neurology.

[4]  Hagai Bergman,et al.  Next generation programming , 2018, Movement disorders : official journal of the Movement Disorder Society.

[5]  Lars Timmermann,et al.  Pulse duration settings in subthalamic stimulation for Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[6]  P. Krack,et al.  Reversing dopaminergic sensitization , 2017, Movement disorders : official journal of the Movement Disorder Society.

[7]  P. Krack,et al.  Current applications and limitations of surgical treatments for movement disorders , 2017, Movement disorders : official journal of the Movement Disorder Society.

[8]  M Muthuraman,et al.  Effect of high‐frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta‐analysis , 2017, European journal of neurology.

[9]  A. Lozano,et al.  Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms , 2016, Brain Stimulation.

[10]  Alberto J Espay,et al.  Computer‐Guided Deep Brain Stimulation Programming for Parkinson's Disease , 2016, Neuromodulation : journal of the International Neuromodulation Society.

[11]  C. McIntyre,et al.  The Use of Stimulation Field Models for Deep Brain Stimulation Programming , 2015, Brain Stimulation.

[12]  Pierre-François D'Haese,et al.  Use of efficacy probability maps for the post-operative programming of deep brain stimulation in essential tremor. , 2014, Parkinsonism & related disorders.

[13]  G. Deuschl,et al.  Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.

[14]  L. Bour,et al.  Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.

[15]  G. Deuschl,et al.  Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. , 2013, Parkinsonism & related disorders.

[16]  P. Pollak,et al.  Psychostimulant effect of levodopa: reversing sensitisation is possible , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  Jay L. Alberts,et al.  Improving postural stability via computational modeling approach to deep brain stimulation programming , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[18]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[19]  Grant D. Huang,et al.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.

[20]  C. Moreau,et al.  STN-DBS frequency effects on freezing of gait in advanced Parkinson disease , 2008, Neurology.

[21]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[22]  J. Volkmann,et al.  Basic algorithms for the programming of deep brain stimulation in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[23]  Michele Tagliati,et al.  Calculating total electrical energy delivered by deep brain stimulation systems , 2005, Annals of neurology.

[24]  C. Tanner,et al.  Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.

[25]  J. Volkmann,et al.  Introduction to the programming of deep brain stimulators , 2002, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Yelnik.  Functional anatomy of the basal ganglia , 2002, Movement disorders : official journal of the Movement Disorder Society.

[27]  Alexandre Mendes,et al.  Postoperative management of subthalamic nucleus stimulation for Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[28]  Y. Agid,et al.  Levodopa‐induced dyskinesias in Parkinson's disease: Is sensitization reversible? , 2000 .

[29]  R. Fitzpatrick,et al.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. , 1997, Age and ageing.

[30]  A. Benabid,et al.  Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus , 1991, The Lancet.